TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT04806165

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Repeated Administration
Description: A discussion with the chatbot, including follow ups over the course of 2 weeks to encourage help seeking for their eating disorder.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Personalized Recommendation
Description: A discussion with the chatbot, including identifying a personalized recommendation for accessing help for their eating disorder.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Motivational Interviewing
Description: A discussion with the chatbot, including motivational interviewing techniques to help overcome barriers to seeking care for their eating disorder.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Core Modules Only
Description: A discussion with the chatbot, including only the core modules.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Motivational Interviewing, Personalized Recommendation, Repeated Administration
Description: A discussion with the chatbot, including motivational interviewing techniques to help overcome barriers to seeking care for their eating disorder, identifying a personalized recommendation for accessing help for their eating disorder, and follow ups over the course of 2 weeks to encourage help seeking for their eating disorder.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Motivational Interviewing, Repeated Administration
Description: A discussion with the chatbot, including motivational interviewing techniques to help overcome barriers to seeking care for their eating disorder and follow ups over the course of 2 weeks to encourage help seeking for their eating disorder.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Motivational Interviewing, Personalized Recommendation
Description: A discussion with the chatbot, including motivational interviewing techniques to help overcome barriers to seeking care for their eating disorder and identifying a personalized recommendation for accessing help for their eating disorder.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Personalized Recommendation, Repeated Administration
Description: A discussion with the chatbot, including identifying a personalized recommendation for accessing help for their eating disorder and follow ups over the course of 2 weeks to encourage help seeking for their eating disorder.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Psychoeducation
Description: A discussion with the chatbot, including psychoeducational content to increase knowledge related to eating disorders.
Study: NCT05200624

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: 2RT subthreshold nanosecond laser
Description: The 2RT™ Q-switched YAG laser (532nm) delivering 3 nanosecond pulses; 400 um spot size, is a pulsed subthreshold nanosecond (SNL) laser, which uses low energy levels to produce limited effects that selectively target melanosomes within the pigmented retinal pigment epithelial (RPE) cells.

Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: 2RT subthreshold nanosecond laser
Description: The 2RT™ Q-switched YAG laser (532nm) delivering 3 nanosecond pulses; 400 um spot size, is a pulsed subthreshold nanosecond (SNL) laser, which uses low energy levels to produce limited effects that selectively target melanosomes within the pigmented retinal pigment epithelial (RPE) cells.
Study: NCT06466551

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: intravenous catheterization
Description: This randomized experimental study was planned to examine the effect of virtual reality goggles and squeezing a stress ball as a distraction method during intravenous catheter application on pain and fear in children aged 6-12 years.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: intravenous catheterization
Description: This randomized experimental study was planned to examine the effect of virtual reality goggles and squeezing a stress ball as a distraction method during intravenous catheter application on pain and fear in children aged 6-12 years.
Study: NCT06356857

Intervention type: DIAGNOSTIC_TEST
Intervention: Myocardial perfusion imaging (MPI) using [O15]H2O-PET-CT
Description: Re-scan for comparison with initial scan
Study: NCT06210022

Intervention type: DIAGNOSTIC_TEST
Intervention: Neuropsychological Assessment
Description: Cognitive evaluation and clinical monitoring of seizure frequency
Study: NCT05538546

Intervention type: DIAGNOSTIC_TEST
Intervention: Complete blood count
Description: Complete blood count will be conducted at 12th month and 24th month from baseline.

Intervention type: DIAGNOSTIC_TEST
Intervention: Complete blood count
Description: Complete blood count will be conducted at 12th month and 24th month from baseline.

Intervention type: DIAGNOSTIC_TEST
Intervention: Transient elastrography
Description: Transient elastrography, and endoscopy will be conducted at 12th month and 24th month from baseline.

Intervention type: DIAGNOSTIC_TEST
Intervention: Transient elastrography
Description: Transient elastrography, and endoscopy will be conducted at 12th month and 24th month from baseline.

Intervention type: DIAGNOSTIC_TEST
Intervention: Endoscopy
Description: Endoscopy will be conducted at 12th month and 24th month from baseline.

Intervention type: DIAGNOSTIC_TEST
Intervention: Endoscopy
Description: Endoscopy will be conducted at 12th month and 24th month from baseline.
Study: NCT04515329

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cyclosporine
Description: Eye drops taken twice daily.

Intervention type: DRUG
Group type: OTHER
Intervention: Artificial tear
Description: Preservative-free artificial tear drops 4 times a day.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Artificial tear
Description: Preservative-free artificial tear drops 4 times a day.
Study: NCT05164146

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: propofol
Description: during the induction, remimazolam dose was controlled according to sedline (Psi target 40)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: remimazolam
Description: During induction, remimazolam dose was controlled according to sedline (Psi target 40)
Study: NCT04806165

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Psychoeducation, Repeated Administration
Description: A discussion with the chatbot, including psychoeducational content to increase knowledge related to eating disorders and follow ups over the course of 2 weeks to encourage help seeking for their eating disorder.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Psychoeducation, Personalized Recommendation
Description: A discussion with the chatbot, including psychoeducational content to increase knowledge related to eating disorders and identifying a personalized recommendation for accessing help for their eating disorder.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Psychoeducation, Motivational Interviewing
Description: A discussion with the chatbot, including psychoeducational content to increase knowledge related to eating disorders and motivational interviewing techniques to help overcome barriers to seeking care for their eating disorder.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Psychoeducation, Motivational Interviewing, Personalized Recommendation
Description: A discussion with the chatbot, including psychoeducational content to increase knowledge related to eating disorders, motivational interviewing techniques to help overcome barriers to seeking care for their eating disorder, and identifying a personalized recommendation for accessing help for their eating disorder.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Psychoeducation, Personalized Recommendation, Repeated Administration
Description: A discussion with the chatbot, including psychoeducational content to increase knowledge related to eating disorders, identifying a personalized recommendation for accessing help for their eating disorder, and follow ups over the course of 2 weeks to encourage help seeking for their eating disorder.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Psychoeducation, Motivational Interviewing, Repeated Administration
Description: A discussion with the chatbot, including psychoeducational content to increase knowledge related to eating disorders, motivational interviewing techniques to help overcome barriers to seeking care for their eating disorder, and follow ups over the course of 2 weeks to encourage help seeking for their eating disorder.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Psychoeducation, Motivational Interviewing, Personalized Recommendation, Repeated Administration
Description: A discussion with the chatbot, including psychoeducational content to increase knowledge related to eating disorders, motivational interviewing techniques to help overcome barriers to seeking care for their eating disorder, identifying a personalized recommendation for accessing help for their eating disorder, and follow ups over the course of 2 weeks to encourage help seeking for their eating disorder.
Study: NCT05416385

Intervention type: OTHER
Intervention: Carotid Contrast Enhanced Ultrasound
Description: Carotid Contrast-Enhanced Ultrasound (CEUS), a diagnostic ultrasound enhancing agent that opacifies the blood to delineate the vessel walls.
Study: NCT05020496

Intervention type: DRUG
Group type: OTHER
Intervention: Diphenylcyclopropenone (DPCP)
Description: Drug will be applied topically on the skin. It will cause contact hypersensitivity in patients

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Diphenylcyclopropenone (DPCP)
Description: Drug will be applied topically on the skin. It will cause contact hypersensitivity in patients
Study: NCT05326594

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Mckenzie Extension Protocol
Description: Mckenzie Extension Exercise Protocol will be performed by participants in prone position

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Lumbar SNAGs
Description: Lumbar SNAGs will be performed in lumbar flexion and extension in standing Position

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Inferential therapy
Description: 4 pole inferential therapy in combination with superficial heating for 20 minutes

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Heat Therapy
Description: superficial heating for 20 minutes
Study: NCT04890028

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: F-DOPA PET/CT
Description: All subjects will be imaged~1 time injection of 2 MBq/kg of 18F-DOPA
Study: NCT05872581

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Hand scanner instant feedback
Description: Participants will be informed about their hand scanner results of the first hand washing attempt to get individualized feedback about their hand wash performance.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Hand scanner instant feedback
Description: Participants will be informed about their hand scanner results of the first hand washing attempt to get individualized feedback about their hand wash performance.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Video training
Description: Participants will watch a training video about the 7 steps of hand washing after the first hand washing attempt.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Video training
Description: Participants will watch a training video about the 7 steps of hand washing after the first hand washing attempt.
Study: NCT05185167

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Anesthetics, General Desflurane Maintenance
Description: Comparison of dna damage of desflurane maintenance with propofol maintenance according to comet analysis

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Anesthetics, General Propofol Maintenance
Description: Comparison of dna damage of propofol maintenance with desflurane maintenance according to comet analysis
Study: NCT05389865

Intervention type: PROCEDURE
Intervention: Surgery on the proximal aorta (aortic root +/- ascending aorta)
Description: Surgery involving replacing, repairing or reinforcing the proximal aorta (root and ascending aorta)

Intervention type: OTHER
Intervention: Patients diagnosed with thoracic aortopathy but not operated upon
Description: Radiological size criteria or Genetic mutations associated with aortopathies
Study: NCT05910489

Intervention type: OTHER
Intervention: Biomonitoring of MNPLs in biological samples of greenhouse workers and controls
Description: Detection of biomarkers of exposure and genotoxic effect in biological blood, urine, exhalated air condensate, and feces

Intervention type: OTHER
Intervention: Biomonitoring of MNPLs in biological samples of greenhouse workers and controls
Description: Detection of biomarkers of exposure and genotoxic effect in biological blood, urine, exhalated air condensate, and feces
Study: NCT05243225

Intervention type: PROCEDURE
Intervention: Laparoscopic versus open surgical management of post cholecystectomy bile duct injury
Description: Comparison between laparoscopic and open surgical management of post cholecystectomy bile duct injury.

Intervention type: PROCEDURE
Intervention: Laparoscopic versus open surgical management of post cholecystectomy bile duct injury
Description: Comparison between laparoscopic and open surgical management of post cholecystectomy bile duct injury.
Study: NCT05031182

Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: Laparoscopy
Description: The hysterectomy is performed by laparoscopy as described in the EMC.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: vNOTES
Description: The hysterectomy is performed by vNOTES as described Dr BAEKELANDT and this team.
Study: NCT06281197

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Conventional
Description: Le Fort I osteotomy performed with conventional Le Fort

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Subspinal
Description: Osteotomy was performed in the subspinal Le Fort I group that is described by Mommaerts
Study: NCT05935202

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Mitapivat sulfate
Description: Subjects enrolled Maximum dose: will receive Mitapivat during 56 weeks Starting dose: 50 mg BD Maximum dose: 100 mg BD
Study: NCT06035978

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nebivolol
Description: Nebivolol (Nebilet) tablet will be administered orally to patients according to their clinical condition and the decision of the attending physician.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Valsartan and Sacubitril
Description: Valsartan and Sacubitril (Entresto) tablet will be administered orally to patients according to their clinical condition and the decision of the attending physician.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Carvedilol
Description: Carvedilol (Dilatrend) tablet will be administered orally to patients according to their clinical condition and the decision of the attending physician.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bisoprolol
Description: Bisoprolol (Concor) tablet will be administered orally to patients according to their clinical condition and the decision of the attending physician.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Metoprolol
Description: Metoprolol (Betaloc ZOK) tablet will be administered orally to patients according to their clinical condition and the decision of the attending physician.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Spironolactone
Description: Verospiron (Spironolactone) tablet will be administered orally to patients according to their clinical condition and the decision of the attending physician.
Study: NCT06498609

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: iprf
Description: i-PRF with leveling and alignment
Study: NCT03150732

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Systemic nalbuphine
Description: Patients will receive systemic nalbuphine 10 mg
Study: NCT06498609

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: MOPs with leveling and alignment
Description: mop
Study: NCT04658888

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Evalyn Self-Sampling Brush
Description: A self-sampling brush to collect cervical cancer cells for screening purposes.
Study: NCT06358599

Intervention type: DRUG
Intervention: Cisplatin
Description: Neoadjuvant cisplatin-containing combination chemotherapy was defined as the receipt of multiagent systemic chemotherapy initiated within 6 months prior to the date of radical cystectomy
Study: NCT06196372

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: MenoMind intervention group
Description: To implement the MenoMind program, the women in the initiative group were divided into groups of 4-5 according to their convenient days and hours, and it was done via the Zoom© program. MenoMind program was carried out via video on WhatsApp© program for women who could not or did not want to use the Zoom© program. The researcher provided support to the women for eight weeks, in different groups, 2-3 days a week and at different times, depending on their availability. Each session is approximately 50 minutes. lasted. In addition, make-up sessions were organized for women who could not attend the sessions for various reasons or had difficulty complying with the program (day/date).
Study: NCT03710343

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Metformin
Description: Single case ABA study design. Phase B (intervention period) with metformin administered orally (or by gastrostomy tube) for 16 weeks.
Study: NCT06358261

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Diabetes Prevention Patient Activation Clinical Decision Support Tool
Description: Diabetes Prevention Patient Activation Clinical Decision Support Tool will be used by the doctor during the visit to discuss lifestyle management
Study: NCT05230992

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Cryoprobes First
Description: In this experimental group, the Cryoprobe is used in first and the classic biopsy forceps in a second time. This medical device under study is the flexible, single-use Cryoprobe, supplied in sterile condition, 1.1 mm in diameter, 1150 mm long, with extraction tube, 817 mm long (reference 20402-401), or 757 mm long (reference 20402-402) marketed. These cryoprobes are covered by a CE marking. Cryoprobes must be used in conjunction with the Erbecryo®2 device and its accessories.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Cryoprobes Second
Description: In this second experimental group, the same medical devices are used but in the other order.
Study: NCT03150732

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Local nalbuphine
Description: Patients will receive local nalbuphine 10 mg
Study: NCT05630976

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Isavuconazole
Description: This is a single arm study, all enrolled participants will receive the study intervention.
Study: NCT05832866

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Clinical Based Isometric contraction strengthening Exercises using Thera band
Description: Patients did isometric contraction exercises using thera band in the clinic physically. They did not need to be monitored by telephone
Study: NCT06115811

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Radiation Treatment Plan Evaluation Learning Tool
Description: Web-based program comprised of a systematic, oncology treatment plan review system and learning modules. The case bank of radiation treatments plans is accessible via econtour.org.
Study: NCT04168879

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Bupivacaine 0.5% Preservative-Free Injectable Solution
Description: 1.5 ml of Bupivacaine 0.5% Preservative-Free Injectable Solution used to block the sphenopalatine ganglion by ultrasound guided suprazygomatic approach

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: normal saline
Description: 1.5 ml of normal saline is delivered to the sphenopalatine ganglion by ultrasound guided suprazygomatic approach
Study: NCT06383104

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Intervention
Description: Three myofascial release techniques will be performed with low load and long duration stretching to the myofascial complex to restore optimal length, decrease pain and improve function. In the development of the deep myofascial techniques, respiratory synchronisation with the patient will be performed. Proprioceptive neuromuscular facilitation techniques will be performed by executing diagonal spiral movements against resistance, several times, through a full range of motion. Three sets of three repetitions with 6-second contractions and a 30-second rest between sets shall be performed.
Study: NCT06113575

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: NeuroStar TMS
Description: NeuroStar TMS treatment - 90-120% of Observed MT, 3 pulses/burst, 5 bursts/sec, 2 sec stimulation, 20 msec interval, 20 trains, 600 total pulses/session for 36 treatments in 5 days. 6 treatments on day 1, 8 treatments on days 2, 3, and 4, 6 treatments on day 5.
Study: NCT05855031

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Transient Elastography
Description: One transient elastography 1-2 weeks after randomization
Study: NCT05826886

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Emotional Writing
Description: Participants complete four 20-minute sessions of emotional writing (at home) on four consecutive days. Instructions are provided online before each writing session.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Emotional Writing
Description: Participants complete four 20-minute sessions of emotional writing (at home) on four consecutive days. Instructions are provided online before each writing session.
Study: NCT04691427

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Virtual Eye Rotation Vision Exercises (VERVE)
Description: A video game designed with elements of vision therapy will be delivered to participants utilizing consumer-available virtual reality headsets (VIVE Pro Eye).
Study: NCT06339697

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: different types of laxatives (compounded polyethylene glycol electrolyte dispersions and compounded sodium pico-sulfate)
Description: Bowel preparation with different types of laxatives (compounded polyethylene glycol electrolytes and compounded sodium picosulfate)

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: different types of laxatives (compounded polyethylene glycol electrolyte dispersions and compounded sodium pico-sulfate)
Description: Bowel preparation with different types of laxatives (compounded polyethylene glycol electrolytes and compounded sodium picosulfate)
Study: NCT05853419

Intervention type: DEVICE
Intervention: Robotic-assisted PCI
Description: Robotic-assisted PCI will be performed according to the routine hospital practices, current scientific guidelines and following Instructions for Use (IFU) provided by the manufacturer
Study: NCT05643872

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PTX-022
Description: QTORIN rapamycin 3.9% anhydrous gel